Precision Vibration Therapy for Neuromuscular and Functional Improvement in Older Adults and Stroke Survivors

ConditionsAgingStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-95
SponsorNational Health Research Institutes, Taiwan

About this trial

To address muscle weakness, sensory degradation, functional decline, and pain caused by geriatric syndromes in older adults and stroke survivors, this project proposes a series of studies aimed at improving neuromuscular performance, muscle strength, proprioceptive gain, functional outcomes, and pain relief through the use of a precise vibration system.

In the first phase, a vibration exercise system will be implemented to recruit frail older adults and older adults with stroke for clinical trials. The goal is to verify the benefits of vibration intervention on limb muscle strength, proprioception, and movement function.

In the third phase, quantitative pain assessments and related scales will be used to evaluate chronic pain thresholds and affected regions in older adults and stroke survivors, and to validate the effectiveness of vibration intervention in alleviating their pain.

Eligibility criteria

Qualifiers

Meet two or more criteria of the Study of Osteoporotic Fractures (SOF) frailty index

Willing to participate in the study and comply with all study procedures

Able to wear and safely use the vibration device

Normal cognitive function (Mini-Mental State Examination [MMSE] score ≥ 23)

Disqualifiers

Acute or chronic neurological injury involving the upper or lower limbs within the past 6 months

Acute or chronic musculoskeletal injury involving the upper or lower limbs within the past 6 months

History of surgery on the upper or lower limbs within the past 6 months

Recurrent stroke during the current episode (i.e., acute re-stroke) or otherwise clinically unstable stroke presentation

Trial design

Treatments tested in this trial

  • Precision Vibration Therapy
  • Conventional Rehabilitation

Treatment groups

80 Participants
are divided into 4 treatment groups